Chang Chen

发表

Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism

Xuerui Tan, Yequn Chen, Yanhong Zhang, 2016, PloS one.

Analysis of Circulating Cholesterol Levels as a Mediator of an Association Between ABO Blood Group and Coronary Heart Disease

X. Ke, Xuerui Tan, Yongying Shi, 2014, Circulation. Cardiovascular genetics.

Association of Impaired Fasting Blood Glucose With Triple Coronary Artery Stenosis and Myocardial Infarction Among Patients With Coronary Artery Stenosis

Xuerui Tan, Yequn Chen, Chang Chen, 2022, Frontiers in Cell and Developmental Biology.

Non-O blood group is associated with lower risk of in-hospital mortality in non-surgically managed patients with type A aortic dissection

Xuerui Tan, Yequn Chen, Chang Chen, 2020, BMC Cardiovascular Disorders.

Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial

Xuerui Tan, Yequn Chen, Chang Chen, 2021, Trials.

Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction.

Xuerui Tan, Yequn Chen, Chang Chen, 2017, International journal of cardiology.

Predicting All-Cause Mortality Risk in Atrial Fibrillation Patients: A Novel LASSO-Cox Model Generated From a Prospective Dataset

Xuerui Tan, Yequn Chen, Chang Chen, 2021, Frontiers in Cardiovascular Medicine.

HBSP protects cardiomyocytes from hypoxia/reoxygenation-induced autophagy through the PI3K/Akt pathway.

Zhuomin Wu, Yequn Chen, Chang Chen, 2020, Journal of cardiovascular pharmacology.

Erythropoietin helix B surface peptide modulates miR-21/Atg12 axis to alleviates cardiomyocyte hypoxia-reoxygenation injury.

Zhuomin Wu, Yequn Chen, Chang Chen, 2019, American journal of translational research.

A novel biodegradable polymer-coated sirolimus-eluting stent: 1-year results of the HELIOS registry

Chang Chen, Rutao Wang, Bo Zheng, 2023, Chinese medical journal.

Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction.

Xuerui Tan, Yequn Chen, Chang Chen, 2017, International journal of cardiology.